We finally constructed glycolysis risk score (GRS) predictive models based on four targeting genes (ADM, CD44, MKI67 and TYMS), which were highly upregulated in tumor samples, including papillary and follicular thyroid cancers (Supplemental Figure 3). The gene discussed is CD44; the disease is neoplasm.